FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018158308> ?p ?o ?g. }

• W3018158308 endingPage "1170" @default.
• W3018158308 startingPage "1163" @default.
• W3018158308 abstract "Abstract Background The aim of this study was to evaluate whether adjuvant chemotherapy is associated with improved survival in patients with resectable gastric neuroendocrine carcinomas (G-NECs) or mixed adenoneuroendocrine carcinomas (G-MANECs). Methods The study included patients with G-NECs or G-MANECs who underwent surgery in one of 21 centres in China between 2004 and 2016. Propensity score matching analysis was used to reduce selection bias, and overall survival (OS) in different treatment groups was estimated by the Kaplan–Meier method. Results In total, 804 patients with resectable G-NECs or G-MANECs were included, of whom 490 (60·9 per cent) received adjuvant chemotherapy. After propensity score matching, OS in the chemotherapy group was similar to that in the no-chemotherapy group. Among patients with G-NECs, survival in the fluorouracil (5-FU)-based chemotherapy group and the non-5-FU-based chemotherapy group was similar to that in the no-chemotherapy group. Similarly, etoposide plus cisplatin or irinotecan plus cisplatin was not associated with better OS in patients with G-NECs. Among patients with G-MANECs, OS in the non-5-FU-based chemotherapy group was worse than that in the no-chemotherapy group. Patients with G-MANECs did not have better OS when platinum-based chemotherapy was used. Conclusion There was no survival benefit in patients who received adjuvant chemotherapy for G-NECs or G-MANECs." @default.
• W3018158308 created "2020-05-01" @default.
• W3018158308 creator A5000964982 @default.
• W3018158308 creator A5002196001 @default.
• W3018158308 creator A5003688758 @default.
• W3018158308 creator A5015117129 @default.
• W3018158308 creator A5020038971 @default.
• W3018158308 creator A5021062151 @default.
• W3018158308 creator A5026430588 @default.
• W3018158308 creator A5026694900 @default.
• W3018158308 creator A5027033821 @default.
• W3018158308 creator A5028494561 @default.
• W3018158308 creator A5030885643 @default.
• W3018158308 creator A5031251029 @default.
• W3018158308 creator A5031420045 @default.
• W3018158308 creator A5031930453 @default.
• W3018158308 creator A5037140449 @default.
• W3018158308 creator A5041801417 @default.
• W3018158308 creator A5042827107 @default.
• W3018158308 creator A5045040327 @default.
• W3018158308 creator A5047453037 @default.
• W3018158308 creator A5055606154 @default.
• W3018158308 creator A5056269486 @default.
• W3018158308 creator A5057347003 @default.
• W3018158308 creator A5058827481 @default.
• W3018158308 creator A5063096622 @default.
• W3018158308 creator A5065478162 @default.
• W3018158308 creator A5067198976 @default.
• W3018158308 creator A5070247723 @default.
• W3018158308 creator A5073199916 @default.
• W3018158308 creator A5084766516 @default.
• W3018158308 date "2020-04-23" @default.
• W3018158308 modified "2023-10-16" @default.
• W3018158308 title "Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas" @default.
• W3018158308 cites W1489437642 @default.
• W3018158308 cites W2027170387 @default.
• W3018158308 cites W2084793761 @default.
• W3018158308 cites W2113947048 @default.
• W3018158308 cites W2227093581 @default.
• W3018158308 cites W2502134830 @default.
• W3018158308 cites W2587630349 @default.
• W3018158308 cites W2685015775 @default.
• W3018158308 cites W2757817502 @default.
• W3018158308 cites W2766559881 @default.
• W3018158308 cites W2775732618 @default.
• W3018158308 cites W2896864991 @default.
• W3018158308 cites W2914976158 @default.
• W3018158308 cites W4246328459 @default.
• W3018158308 doi "https://doi.org/10.1002/bjs.11608" @default.
• W3018158308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32323879" @default.
• W3018158308 hasPublicationYear "2020" @default.
• W3018158308 type Work @default.
• W3018158308 sameAs 3018158308 @default.
• W3018158308 citedByCount "10" @default.
• W3018158308 countsByYear W30181583082021 @default.
• W3018158308 countsByYear W30181583082022 @default.
• W3018158308 countsByYear W30181583082023 @default.
• W3018158308 crossrefType "journal-article" @default.
• W3018158308 hasAuthorship W3018158308A5000964982 @default.
• W3018158308 hasAuthorship W3018158308A5002196001 @default.
• W3018158308 hasAuthorship W3018158308A5003688758 @default.
• W3018158308 hasAuthorship W3018158308A5015117129 @default.
• W3018158308 hasAuthorship W3018158308A5020038971 @default.
• W3018158308 hasAuthorship W3018158308A5021062151 @default.
• W3018158308 hasAuthorship W3018158308A5026430588 @default.
• W3018158308 hasAuthorship W3018158308A5026694900 @default.
• W3018158308 hasAuthorship W3018158308A5027033821 @default.
• W3018158308 hasAuthorship W3018158308A5028494561 @default.
• W3018158308 hasAuthorship W3018158308A5030885643 @default.
• W3018158308 hasAuthorship W3018158308A5031251029 @default.
• W3018158308 hasAuthorship W3018158308A5031420045 @default.
• W3018158308 hasAuthorship W3018158308A5031930453 @default.
• W3018158308 hasAuthorship W3018158308A5037140449 @default.
• W3018158308 hasAuthorship W3018158308A5041801417 @default.
• W3018158308 hasAuthorship W3018158308A5042827107 @default.
• W3018158308 hasAuthorship W3018158308A5045040327 @default.
• W3018158308 hasAuthorship W3018158308A5047453037 @default.
• W3018158308 hasAuthorship W3018158308A5055606154 @default.
• W3018158308 hasAuthorship W3018158308A5056269486 @default.
• W3018158308 hasAuthorship W3018158308A5057347003 @default.
• W3018158308 hasAuthorship W3018158308A5058827481 @default.
• W3018158308 hasAuthorship W3018158308A5063096622 @default.
• W3018158308 hasAuthorship W3018158308A5065478162 @default.
• W3018158308 hasAuthorship W3018158308A5067198976 @default.
• W3018158308 hasAuthorship W3018158308A5070247723 @default.
• W3018158308 hasAuthorship W3018158308A5073199916 @default.
• W3018158308 hasAuthorship W3018158308A5084766516 @default.
• W3018158308 hasBestOaLocation W30181583081 @default.
• W3018158308 hasConcept C121608353 @default.
• W3018158308 hasConcept C126322002 @default.
• W3018158308 hasConcept C143998085 @default.
• W3018158308 hasConcept C17923572 @default.
• W3018158308 hasConcept C2776694085 @default.
• W3018158308 hasConcept C2777863537 @default.
• W3018158308 hasConcept C2778119113 @default.
• W3018158308 hasConcept C2778239845 @default.
• W3018158308 hasConcept C2780259306 @default.
• W3018158308 hasConcept C526805850 @default.

• next